In‐Kyung Song
Papers
1
Total Citations
16
H-Index
1
About
In-Kyung Song is a clinical researcher whose work centers on postoperative pain management and novel analgesic development, with a particular focus on the affective—or emotional—components of pain. Her most cited study investigates VVZ-149, a dual-action small molecule that inhibits the glycine transporter type 2 and the serotonin receptor 5-HT2A. In a randomized, double-blind, proof-of-concept trial involving patients recovering from laparoscopic and robotic-laparoscopic gastrectomy, Song demonstrated that VVZ-149 significantly reduced pain’s affective dimension, offering a new approach beyond traditional opioid-based therapies. This work, published in 2021 and garnering 16 citations, represents an early but promising contribution to non-opioid analgesia. Song’s research is notable for bridging molecular pharmacology with patient-centered outcomes, addressing both sensory and emotional pain pathways. Her findings have implications for enhanced recovery after surgery protocols and the ongoing effort to mitigate opioid dependence. As an emerging voice in perioperative medicine, Song continues to explore how targeted therapies can transform the surgical recovery experience.
Research Focus
Key Achievements
Top Papers
- 1